Seth T. Housman

667 total citations
24 papers, 557 citations indexed

About

Seth T. Housman is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Seth T. Housman has authored 24 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 14 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Seth T. Housman's work include Antibiotics Pharmacokinetics and Efficacy (18 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Antibiotic Resistance in Bacteria (9 papers). Seth T. Housman is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (18 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Antibiotic Resistance in Bacteria (9 papers). Seth T. Housman collaborates with scholars based in United States, Japan and Saudi Arabia. Seth T. Housman's co-authors include David P. Nicolau, Joseph L. Kuti, Eric Shore, J. Samuel Pope, Mao Hagihara, Jared L. Crandon, Christina Sutherland, Wright W. Nichols, Richard Quintiliani and Amira A. Bhalodi and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Infection Control and Hospital Epidemiology.

In The Last Decade

Seth T. Housman

24 papers receiving 544 citations

Peers

Countries citing papers authored by Seth T. Housman

Since Specialization

Citations

This map shows the geographic impact of Seth T. Housman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth T. Housman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth T. Housman more than expected).

Fields of papers citing papers by Seth T. Housman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth T. Housman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth T. Housman. The network helps show where Seth T. Housman may publish in the future.

Co-authorship network of co-authors of Seth T. Housman

This figure shows the co-authorship network connecting the top 25 collaborators of Seth T. Housman. A scholar is included among the top collaborators of Seth T. Housman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth T. Housman. Seth T. Housman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of an online calculator’s vancomycin dosing and exposure appropriateness in persons who inject drugs with methicillin‐resistant Staphylococcus aureus bloodstream infections 2022 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), Seth T. Housman, (unknown), (unknown)	1
2	Ertapenem Concentrations in Obese Patients Undergoing Surgery 2022 ·Surgical Infections ·Seth T. Housman, (unknown), Philip S. Barie, David P. Nicolau	3
3	In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium 2019 ·Journal of Antimicrobial Chemotherapy ·(unknown), James M. Kidd, Stephen G. Jenkins, David P. Nicolau, Seth T. Housman	11
4	What's new in the treatment of multidrug-resistant gram-negative infections? 2018 ·Diagnostic Microbiology and Infectious Disease ·(unknown), (unknown), (unknown), Kamaljit Kaur, Seth T. Housman	27
5	Vancomycin Tissue Pharmacokinetics in Patients with Lower-Limb Infections via In Vivo Microdialysis 2015 ·Journal of the American Podiatric Medical Association ·Seth T. Housman, Amira A. Bhalodi, (unknown), (unknown), David P. Nicolau	14
6	Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection 2015 ·Journal of Hospital Infection ·Abrar K. Thabit, Seth T. Housman, Carey‐Ann D. Burnham, David P. Nicolau	3
7	Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin 2015 ·Infection Control and Hospital Epidemiology ·Seth T. Housman, Abrar K. Thabit, Joseph L. Kuti, Richard Quintiliani, David P. Nicolau	25
8	Isolation and quantitation of Clostridium difficile in aqueous and fecal matter using two types of selective media 2015 ·Journal of Microbiology Immunology and Infection ·Seth T. Housman, Mary Anné Banevicius, Lucinda Lamb, David P. Nicolau	5
9	Assessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for Commonly Utilized Parenteral Agents against Methicillin-Susceptible Staphylococcus aureus: Focus on Ceftriaxone Discordance between Predictive Susceptibility and in Vivo Exposures 2015 ·Pathogens ·(unknown), Seth T. Housman, David P. Nicolau	8
10	Humanized tissue pharmacodynamics of cefazolin against commonly isolated pathogens in skin and skin structure infections 2014 ·Journal of Antimicrobial Chemotherapy ·(unknown), Seth T. Housman, David P. Nicolau	5
11	In vitro microdialysis membrane efficiency of broad-spectrum antibiotics in combination and alone 2014 ·Clinical Pharmacology Advances and Applications ·David P. Nicolau, Shawn H. MacVane, Seth T. Housman	10
12	Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals 2014 ·International Journal of Antimicrobial Agents ·Seth T. Housman, Christina Sutherland, David P. Nicolau	34
13	In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii 2013 ·Journal of Antimicrobial Chemotherapy ·Seth T. Housman, Mao Hagihara, David P. Nicolau, Joseph L. Kuti	29
14	Efficacies of Ceftazidime-Avibactam and Ceftazidime against Pseudomonas aeruginosa in a Murine Lung Infection Model 2013 ·Antimicrobial Agents and Chemotherapy ·Seth T. Housman, Jared L. Crandon, Wright W. Nichols, David P. Nicolau	51
15	Tissue Pharmacokinetics of Cefazolin in Patients with Lower Limb Infections 2013 ·Antimicrobial Agents and Chemotherapy ·Amira A. Bhalodi, Seth T. Housman, (unknown), (unknown), David P. Nicolau	25
16	Comparative Pharmacokinetics, Pharmacodynamics, and Tolerability of Ertapenem 1 Gram/Day Administered as a Rapid 5‐Minute Infusion versus the Standard 30‐Minute Infusion in Healthy Adult Volunteers 2013 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Dora E. Wiskirchen, Seth T. Housman, Richard Quintiliani, David P. Nicolau, Joseph L. Kuti	31
17	Efficacy of Human Simulated Exposures of Ceftaroline against Phenotypically Diverse Enterobacteriaceae Isolates 2012 ·Antimicrobial Agents and Chemotherapy ·Seth T. Housman, Rebecca A. Keel, Jared L. Crandon, G. Williams, David P. Nicolau	7
18	Optimizing Antibiotic Pharmacodynamics in Hospital-acquired and Ventilator-acquired Bacterial Pneumonia 2011 ·Clinics in Chest Medicine ·Seth T. Housman, Joseph L. Kuti, David P. Nicolau	5
19	Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration 2011 ·American Journal of Health-System Pharmacy ·Seth T. Housman, Pamela R. Tessier, David P. Nicolau, Joseph L. Kuti	11
20	In Vitro Evaluation of Novel Compounds against Selected Resistant Pseudomonas aeruginosa Isolates 2011 ·Antimicrobial Agents and Chemotherapy ·Seth T. Housman, Christina Sutherland, David P. Nicolau	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact